Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Email

Bradley Scroggins

  • Program Director, TRP
  • Division of Cancer Treatment and Diagnosis (DCTD)
  • Translational Research Program
240-276-7860 |

Program Director

Translational Research Program

Portfolios: Bladder, Prostate, Kidney, Hyperactive RAS, Radiation and Radiosensitization

Bradley Scroggins, PhD, has served as a Program Director in the Translational Research Program within the Division of Cancer Treatment and Diagnosis (DCTD), National Cancer Institute (NCI) since 2023. Prior to joining, Dr. Scroggins worked in the NCI intramural Radiation Oncology Branch and the Urologic Oncology Branch. Dr. Scroggins has expertise in preclinical models of prostate, bladder, kidney cancer, radiation oncology and normal tissue damage, and protein homeostasis. 

 

  • Updated:
Email